MINOCA-TR: Myocardial Infarction With Non-obstructive Coronary Arteries in Turkish Population

Sponsor
Cardiovascular Academy Society, Turkey (Other)
Overall Status
Completed
CT.gov ID
NCT03364387
Collaborator
(none)
16,026
1
3.4
4782.3

Study Details

Study Description

Brief Summary

The objective of this study is to analyze the Demographics, Clinical Profiles, Management, in-Hospital and Long-Term Outcomes of Patients with Acute Coronary Syndrome Syndrome And Myocardial Infarction with Non-obstructive Coronary Artery Disease.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Acute coronary syndrome is leading causes of death worldwide. Although, >90% of these patients had of culprit coronary lesion, a significant proportion of them had no any angiographic evidence of obstructive coronary arteries. Exact mechanism of the myocardial infarction remains unclear of these patients. However, MI registries have reported that the 5% to %10 of MI patients have no evidence of obstructive coronary artery disease.

    There is lack of any data regarding prevalence, demographics, patients' profile, management, and outcome of this clinical entity in Turkish population. This registry aims to obtain these data in Myocardial Infarction with Non-obstructive Coronary Artery Disease patients in Turkish population.

    Although there are huge data in this issue from different country and geographic areas, to date no any national data about prevalence, demographics, management and in-hospital outcomes of AF patients who admitting with cute coronary syndrome. With this rationale the registry also aims to obtain demographics, clinical profile, management, and in-hospital outcome of AF in Turkish Acute coronary syndrome population.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    16026 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Clinical Profile, Management and Long-Term Outcomes of Patients With Acute Coronary Syndrome and Myocardial Infarction With Non-obstructive Coronary Arteries in Turkish Population
    Actual Study Start Date :
    Mar 5, 2018
    Actual Primary Completion Date :
    May 15, 2018
    Actual Study Completion Date :
    Jun 15, 2018

    Outcome Measures

    Primary Outcome Measures

    1. Composites of Myocardial Infarction, Hospitalization, Revascularization, Death [12 months]

      Re-infarction, Any cause or Cardiovascular Hospitalization or Death

    Secondary Outcome Measures

    1. Atrial Fibrillation [12 months]

      Any type of atrial fibrillation

    2. Heart failure [12 months]

      Acute decompensated heart failure with or without cardiogenic shock

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    1. Patients older than 18 years

    2. Evidence of an MI as defined any one of the following criteria:

    Detection of a rise and/or fall of cardiac biomarker values [preferably cardiac troponin (cTn)] with at least one value above the 99th percentile upper reference limit (URL) and with at least one of the following:

    1. Symptoms of ischaemia. ii. New or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block (LBBB).

    2. Development of pathological Q waves in the ECG. iv. Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality.

    3. Identification of an intracoronary thrombus by angiography.

    1. Invasive diagnostic coronary angiography (IDCA) findings to allow determination of the presence /absence of obstructive coronary artery disease

    2. Signed informed consent form to trial participation

    Exclusion Criteria:
    1. Inability/Refused to provide informed consent

    2. Age below 18 years

    3. Patients with unstable angina pectoris (ACS without increase and/or decrease of a cardiac biomarker, preferably high-sensitivity cardiac troponin, with at least one value above the 99th percentile of the upper reference limit)

    4. Patients refused invasive diagnostic coronary angiography

    5. Myocardial infarction associated with revascularization procedures

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Emin Alioğlu Izmir Turkey

    Sponsors and Collaborators

    • Cardiovascular Academy Society, Turkey

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Cardiovascular Academy Society, Turkey
    ClinicalTrials.gov Identifier:
    NCT03364387
    Other Study ID Numbers:
    • MINOCA-TR
    First Posted:
    Dec 6, 2017
    Last Update Posted:
    Jul 24, 2018
    Last Verified:
    Jul 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Cardiovascular Academy Society, Turkey
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 24, 2018